News | He Yaqiong, Director of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology, investigated Yinfeng Biological Group
Release time:
2023-06-03
On June 3, 2023, He Yaqiong, Director of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology, and his delegation came to Shandong Province to investigate the development of the biomedicine and biomanufacturing industry. Zhang Haibo, Secretary of the Party Group and Director of the Shandong Provincial Department of Industry and Information Technology, accompanied the investigation. In Jinan, He Yaqiong went deep into Yinfeng Biological Group to investigate and listen to the introduction. Wang Wei, Chairman of Yinfeng Group, and Chen Shoulin, Vice President of Yinfeng Biological Group, accompanied the visit.
In Yinfeng Biotechnology Park, the research team inspected the technology research and development and medical transformation of Yinfeng Biological Group in the biomedical fields such as stem cells, organ storage, and gene sequencing, fully affirmed the achievements of Yinfeng Biological Group in promoting biomedicine, and encouraged Yinfeng Biological Group to continue to build a health management service industry chain covering the whole life cycle of human beings.
He Yaqiong said that she hopes that the company will adhere to the path of high-quality pharmaceutical development, continue to increase research and development efforts, improve innovation capabilities, and contribute to China's biomedical level in the forefront of the world.
Since 2003, Yinfeng Group has developed into a high-tech enterprise specializing in technology research and development, medical transformation and clinical research in the biomedical fields such as human cells, tissues and organ storage, gene sequencing, cell application, cryogenic medicine and health management services. With 20 years of deep cultivation in the industry, Yinfeng Biological Group has taken Jinan as the center, with an industrial layout in 19 provinces and cities across the country, and set up R&D institutions in the United States.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
